Skip to main content
SpringerLink
Log in

DNA ploidy level and S-phase fraction as prognostic factors in breast cancer

  • Original Articles
  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

Imprint smears from sixty cases of breast cancer made after mastectomy were stained by the Feulgen method and the nuclear DNA content measured by a cytofluorometer equipped with an incident illumination system. After logarithmic transformation of the fluorescence intensity, the ploidy level and S-phase fraction (SPF) were calculated with a microcomputer and the correlation between the ploidy level or SPF and the clinicopathological prognostic factors studied. Patients with tumors of a larger diameter and more extensive lymph node involvement had higher levels of ploidy and SPF and the ploidy level in the metastatic lymph nodes was higher than that in the primary lesion. Moreover, a significant increase in SPF was observed in the metastatic lymph nodes and a high ploidy level found to be associated with tumors having a negative estrogen receptor. When the tumors were divided into a diploid group and an aneuploid group, the diploid group showed a significantly better prognosis than the aneuploid group, in 6-year survival. Similarly, the groups in which SPF was less than 20.0 per cent had significantly better prognoses than the group in which SPF was 20.1 per cent or more. These prognostic factors were evaluated with Cox's proportional hazard model and a significant correlation observed in lymph node status, ER status, ploidy level and S-phase fraction. It was thus concluded that ploidy level and SPF are important and independent prognostic factors for predicting the postoperative course of breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Atkin NB. Modal deoxyribonucleic acid value and survival in carcinoma of the breast. Brit Med J 1972; 29: 271–272.

    Article  Google Scholar 

  2. Meyer JS, Lee JY. Relationship of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival. Cancer Res 1980; 40: 1890–1896.

    PubMed  CAS  Google Scholar 

  3. Auel GU, Caspersson TO, Wallgren AS. DNA content and survival in mammary carcinoma. Anal Quant Cytl 1980; 2: 161–165.

    Google Scholar 

  4. Straus MJ, Moran RE. The cell cycle kinetics of human breast cancer. Cancer 1980; 46: 2639–2643.

    Google Scholar 

  5. Gentili C, Sanfilippo O, Silvestrini R. Cell proliferation and its relationship to clinical features and relapse in breast cancer. Cancer 1981; 48: 974–979.

    Article  PubMed  CAS  Google Scholar 

  6. Olszewski W, Darzynkiewicz Z, Rose PP, Schwartz MK, Melamed MR. Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer 1981; 48: 980–984.

    Article  PubMed  CAS  Google Scholar 

  7. Olszewski W, Darzynkiewicz Z, Rose PP, Schwartz MK, Melamed MR. Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor. Cancer 1981; 48: 985–988.

    Article  PubMed  CAS  Google Scholar 

  8. Kute TE, Muss HB, Anderson D, Crumb K, Miller B, Burns D, Dube LA. Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer. Cancer Res 1981; 41: 3524–3529.

    PubMed  CAS  Google Scholar 

  9. Bichel P, Poulsen S, Anderson J. Estrogen receptor content and ploidy of human mammary carcinoma. Cancer 1982; 50: 1771–1774.

    Article  PubMed  CAS  Google Scholar 

  10. Meyer JS, Friedman E, McCrate M, Bauer WC. Prediction of early course of breast carcinoma by thymidine labeling. Cancer 1983; 51: 1886–1887.

    Article  Google Scholar 

  11. Taylor IW, Musgrove EA, Friedlander ML, Foo MS, Hedley DW. The influence of age on the DNA ploidy levels of breast tumors. Eur J Cancer Clin Oncol 1983; 19: 623–628.

    Article  PubMed  CAS  Google Scholar 

  12. Hedley DW, Rugg CA, Ng ABP, Taylor IW. Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 1984; 44: 5395–5398.

    PubMed  CAS  Google Scholar 

  13. Moran RE, Black MM, Alpert L, Straus MJ. Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer. Cancer 1984; 54: 1586–1590.

    Article  PubMed  CAS  Google Scholar 

  14. Auer G, Erikson E, Azavedo E, Caspersson T, Wallgren A. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res 1984; 44: 394–396.

    PubMed  CAS  Google Scholar 

  15. Coulson PB, Thornthwaite JT, Woolley TW, Sugarbaker EV, Seckinger D. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Cancer Res 1984; 44: 4187–4196.

    PubMed  CAS  Google Scholar 

  16. Ewers SB, Långström E, Baldetrop B, Killander D. Flow-cytometric DNA analysis in primary breast carcinomas and clinocopathological correlations. Cytometry 1984; 5: 408–419.

    Article  PubMed  CAS  Google Scholar 

  17. Tubiana M, Pejovic MN, Contesso CG, Malaise ER. The long-term prognostic significance of the thymidine labeling index in breast cancer. Int J Cancer 1984; 33: 441–445.

    PubMed  CAS  Google Scholar 

  18. Kute TE, Muss HB, Hopkins M, Marshal R, Case D, Kammire L. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer. Breast Cancer Res Treat 1985; 6: 113–121.

    Article  PubMed  CAS  Google Scholar 

  19. McGuire WL, Meyer JS, Barlogie B, Kute T. Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. Breast Cancer Res Treat 1985; 5: 117–128.

    Article  PubMed  CAS  Google Scholar 

  20. McGuire WL, Dressler LG. Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. J Natl Cancer Inst 1985; 75: 405–410.

    PubMed  CAS  Google Scholar 

  21. Hedley DW, Friedlander ML, Taylor IW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 1985; 6: 327–333.

    Article  PubMed  CAS  Google Scholar 

  22. Kuo SH, Lin CC, Yu SC, Liaw KY, Wei TC. Nuclear DNA content in benign and malignant tumors of breast cancer. J Formosan Med Assoc 1985; 84: 1117–1125.

    CAS  Google Scholar 

  23. Stuart-Harris R, Hedley DW, Taylor IW, Levene AL, Smith IE. Tumor ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer. Br J Cancer 1985; 51: 573–576.

    PubMed  CAS  Google Scholar 

  24. Horsfall DJ, Tilly WD, Orell SR, Marshall VR, Cant ELM. Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer. Br J Cancer 1986; 53: 23–28.

    PubMed  CAS  Google Scholar 

  25. McDivitt RW, Stone KR, Craig RB, Palmer JO, Meyer JS, Bauer WC. A proposed classification on breast cancer based on kinetic information. Derived from a comparison of risk factors in 168 primary operable breast cancers. Cancer 1986; 57: 269–276.

    Article  PubMed  CAS  Google Scholar 

  26. Thorud E, Fosså SD, Vaage S, Kaalhus O, Knudsen OS, Børmer O, Shoaib MC. Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics. Cancer 1986; 57: 808–811.

    Article  PubMed  CAS  Google Scholar 

  27. Hedley DW, Rugg CA, Gelber RD. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 1987; 47: 4729–4735.

    PubMed  CAS  Google Scholar 

  28. Baildam AD, Zalloudik J, Howell A, Barnes DM, Thurnbull L, Swindel R, Moore M, Sellwood RA. DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br J Cancer 1987; 55: 553–559.

    PubMed  CAS  Google Scholar 

  29. Kallioniemi OP, Blauco G, Alvaikko M, Hietanen T, Mattila J, Lauslahti K, Koivula T. Tumor DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 1987; 56: 637–642.

    PubMed  CAS  Google Scholar 

  30. Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988; 61: 420–427.

    Article  PubMed  CAS  Google Scholar 

  31. Fujita S. DNA cytofluorometry on large and small cell nuclei with pararosaniline Feulgen. Histochemie 1973; 193–199.

  32. Fujita S, Fukuda M. Irradiation of specimens by excitation light before and after staining with pararosaniline Feulgen: A new method to reduce non-specific fluorescence in cytofluorometry. Histochemistry 1974; 40: 59–67.

    Article  PubMed  CAS  Google Scholar 

  33. Okagaki T, Izuo M. Correction of modal DNA values obtained by microspectrophotometry and test for their shifts. J Natl Cancer Inst 1978; 6: 1251–1258.

    Google Scholar 

  34. Japan Mammary Cancer Society. General rules for clinical and pathological record of mammary cancer. 7th Ed. Kanehara Pub. Co., Tokyo, 1984.

    Google Scholar 

  35. Cornelisse CJ, van Driel-Kullker AM. DNA image cytometry on machine selected breast cancer cells and a comparison between flow cytometry and scanning cytophotometry. Cytometry 1985; 6: 471–477.

    Article  PubMed  CAS  Google Scholar 

  36. Jakesz R, Smith CA, Aitken S, Huff W, Schuette S, Shackney S, Lippman M. Influence of cell proliferation and cell phase on expression of estrogen receptor in MCF-7 breast cancer cells. Cancer Res 1984; 44: 619–625.

    PubMed  CAS  Google Scholar 

  37. Fallenius AG, Franzen SA; Auer GU. Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. Cancer 1988; 62: 521–530.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Second Department of Surgery, Gunma University School of Medicine, 3-39-15 Showa-machi, 371, Maebashi, Japan

    Takao Yokoe MD, Masaru Izuo, Isunehiro Ishida, Yuichi Iino & Tadakazu Kawai

Authors
  1. Takao Yokoe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaru Izuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isunehiro Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuichi Iino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tadakazu Kawai
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yokoe, T., Izuo, M., Ishida, I. et al. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer. The Japanese Journal of Surgery 20, 491–497 (1990). https://doi.org/10.1007/BF02471003

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02471003

Key Words

Search

Navigation